Jeffrey R. Lavigne

2.4k total citations · 2 hit papers
10 papers, 1.6k citations indexed

About

Jeffrey R. Lavigne is a scholar working on Nephrology, Oncology and Genetics. According to data from OpenAlex, Jeffrey R. Lavigne has authored 10 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Nephrology, 4 papers in Oncology and 4 papers in Genetics. Recurrent topics in Jeffrey R. Lavigne's work include Parathyroid Disorders and Treatments (8 papers), Genetic Syndromes and Imprinting (4 papers) and Bone health and treatments (3 papers). Jeffrey R. Lavigne is often cited by papers focused on Parathyroid Disorders and Treatments (8 papers), Genetic Syndromes and Imprinting (4 papers) and Bone health and treatments (3 papers). Jeffrey R. Lavigne collaborates with scholars based in United States, Sweden and Canada. Jeffrey R. Lavigne's co-authors include R Zahradnik, H. T. Keutmann, S R Nussbaum, G V Segre, John T. Potts, Harald Jüppner, Östen Ljunggren, Geeta Hampson, Hiroyuki Koshiyama and Toshitsugu Sugimoto and has published in prestigious journals such as New England Journal of Medicine, Kidney International and Journal of Bone and Mineral Research.

In The Last Decade

Jeffrey R. Lavigne

10 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fibroblast Growth Factor 23 in Oncogenic Osteomalacia and X-Linked Hypophosphatemia

2003 683 citations Kenneth B. Jonsson, R Zahradnik et al. New England Journal of Medicine profile →
Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia.

1987 653 citations S R Nussbaum, R Zahradnik et al. Clinical Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeffrey R. Lavigne United States	9	1.3k	548	462	365	307	10	1.6k
R Zahradnik Sweden	8	1.2k 0.9×	517 0.9×	440 1.0×	305 0.8×	314 1.0×	8	1.5k
Marie-Claude Monier-Faugere United States	19	1.1k 0.8×	505 0.9×	225 0.5×	385 1.1×	364 1.2×	23	1.7k
Jean‐Hugues Brossard Canada	18	1.2k 0.9×	524 1.0×	321 0.7×	354 1.0×	260 0.8×	26	1.4k
Thomas L. Cantor United States	14	893 0.7×	342 0.6×	222 0.5×	424 1.2×	213 0.7×	16	1.3k
Inga‐Lena Nilsson Sweden	23	942 0.7×	396 0.7×	338 0.7×	264 0.7×	303 1.0×	76	1.6k
Daniela Sardella Italy	19	751 0.6×	266 0.5×	114 0.2×	253 0.7×	187 0.6×	34	1.1k
Martin Tieder Israel	15	845 0.7×	166 0.3×	354 0.8×	340 0.9×	255 0.8×	32	1.3k
Kátia R. Neves Brazil	12	991 0.8×	172 0.3×	181 0.4×	263 0.7×	102 0.3×	15	1.1k
Farzana Perwad United States	15	840 0.6×	144 0.3×	422 0.9×	386 1.1×	275 0.9×	26	1.1k
Masahide Mizobuchi Japan	21	1.3k 1.0×	105 0.2×	345 0.7×	578 1.6×	204 0.7×	59	1.7k

Countries citing papers authored by Jeffrey R. Lavigne

Since Specialization

Citations

This map shows the geographic impact of Jeffrey R. Lavigne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey R. Lavigne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey R. Lavigne more than expected).

Fields of papers citing papers by Jeffrey R. Lavigne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey R. Lavigne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey R. Lavigne. The network helps show where Jeffrey R. Lavigne may publish in the future.

Co-authorship network of co-authors of Jeffrey R. Lavigne

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey R. Lavigne. A scholar is included among the top collaborators of Jeffrey R. Lavigne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey R. Lavigne. Jeffrey R. Lavigne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Brossard, Jean‐Hugues, et al.. (2007). Parathyroid hormone fragments inhibit active hormone and hypocalcemia-induced 1,25(OH)2D synthesis. Kidney International. 72(11). 1330–1335. 39 indexed citations

D'Amour, P, Jean‐Hugues Brossard, Louise Rousseau, et al.. (2005). Structure of non-(1-84) PTH fragments secreted by parathyroid glands in primary and secondary hyperparathyroidism. Kidney International. 68(3). 998–1007. 57 indexed citations

Zahradnik, R, et al.. (2003). Immunohistochemical detection of FGF-23 protein in tumors that cause oncogenic osteomalacia. European Journal of Endocrinology. 148(2). 269–276. 49 indexed citations

Salusky, Isidro B., William G. Goodman, Beatriz D. Kuizon, et al.. (2003). Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis. Kidney International. 63(5). 1801–1808. 83 indexed citations

Jonsson, Kenneth B., R Zahradnik, Tobias E. Larsson, et al.. (2003). Fibroblast Growth Factor 23 in Oncogenic Osteomalacia and X-Linked Hypophosphatemia. New England Journal of Medicine. 348(17). 1656–1663. 683 indexed citations breakdown →

Jonsson, Kenneth B., R Zahradnik, Kenneth E. White, et al.. (2002). FGF-23 is a circulating factor that is elevated in oncogenic osteomalacia and X-linked hypophosphatemic rickets.. Journal of Bone and Mineral Research. 17. 8 indexed citations

Lavigne, Jeffrey R., R Zahradnik, Rebecca L. Conklin, et al.. (1998). Stimulation of Calcitonin Secretion by Calcium Receptor Activators: Evaluation Using a New, Highly Sensitive, Homologous Immunoradiometric Assay for Rat Calcitonin. Endocrine. 9(3). 293–302. 13 indexed citations

Jara, Aquiles, Jordi Bover, Jeffrey R. Lavigne, & Arnold J. Felsenfeld. (1994). Comparison of two parathyroid hormone assays for the rat: The new immunoradiometric and the older competitive binding assay. Journal of Bone and Mineral Research. 9(10). 1629–1633. 7 indexed citations

Garner, Sanford C., et al.. (1994). Determination of bioactive rat parathyroid hormone (PTH) concentrations in vivo and in vitro by a 2-site homologous immunoradiometric assay. Bone and Mineral. 27(2). 121–132. 12 indexed citations

10.

Nussbaum, S R, R Zahradnik, Jeffrey R. Lavigne, et al.. (1987). Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia.. Clinical Chemistry. 33(8). 1364–1367. 653 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact